Company Information & Drug Savings for AstraZeneca Medications

AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with major US operations in Wilmington, Delaware. The company develops breakthrough medicines in oncology, cardiovascular, renal, metabolism, respiratory, and immunology. Key products include Tagrisso (osimertinib) for lung cancer, Lynparza (olaparib) for BRCA-mutated cancers, Farxiga (dapagliflozin) for diabetes and heart failure, Symbicort for asthma and COPD, and COVID-19 vaccines. AstraZeneca’s research-driven approach delivers innovative therapies that transform patient outcomes.

AstraZeneca

How to Contact Astrazeneca

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch